Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Precise Biometrics ABPRBCF 34 Equity-to-Asset is 0.73 as of Mar. 2026, which is 3% below its 10-year median of 0.75. GuruFocus rates PRBCF with a GF Score™ of 34/100 and a GF Value™ of $0.23 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 1,096 Business Services companies, Precise Biometrics AB ranks better than 78.1% on this metric.
The historical rank and industry rank for Precise Biometrics AB's Equity-to-Asset or its related term are showing as below:
PRBCF'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.53 Med: 0.75 Max: 0.86
Current: 0.73
During the past 13 years, the highest Equity to Asset Ratio of Precise Biometrics AB was 0.86. The lowest was 0.53. And the median was 0.75.
PRBCF's Equity-to-Asset is ranked better than 78.1% of 1096
companies
in the Business Services industry
Industry Median: 0.52
vs PRBCF: 0.73
Precise Biometrics AB (OTCPK:PRBCF) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Precise Biometrics AB Equity-to-Asset Related Terms
Precise Biometrics AB Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Precise Biometrics AB's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PRBCF vs ALLE, MSA, ADT: Equity-to-Asset Comparison
For the Security & Protection Services subindustry, Precise Biometrics AB's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Precise Biometrics AB Equity-to-Asset vs Business Services Industry
For the Business Services industry and Industrials sector, Precise Biometrics AB's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Precise Biometrics AB's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Precise Biometrics AB's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Precise Biometrics AB (PRBCF) has a Equity-to-Asset of 0.73 as of Mar. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Precise Biometrics AB and its competitors. This is near median its historical median of 0.75. Over the past decade, Precise Biometrics AB's Equity-to-Asset has ranged from 0.53 to 0.86. According to the industry distribution chart, Precise Biometrics AB ranks #240 out of 1096 companies in the Business Services industry, placing it in the top 21.9%.
Is Precise Biometrics AB's Equity-to-Asset too high?
Precise Biometrics AB's current Equity-to-Asset of 0.73 is near median its 10-year median of 0.75. Over the past 10 years, this metric has ranged from a low of 0.53 to a high of 0.86. The Business Services industry median Equity-to-Asset is 0.52. Precise Biometrics AB's value of 0.73 is 40.4% above this industry median. Based on the distribution chart, Precise Biometrics AB ranks #240 out of 1096 companies in the Business Services industry, which is in the top quartile — a strong position relative to peers. Overall, Precise Biometrics AB has a GF Score™ of 34/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Precise Biometrics AB's Equity-to-Asset compare to ALLE and MSA?
According to the Business Services industry distribution chart, Precise Biometrics AB ranks #240 out of 1096 companies for Equity-to-Asset. This places Precise Biometrics AB in the top 22% of its industry — outperforming the majority of peers. The industry median Equity-to-Asset is 0.52. Precise Biometrics AB's value of 0.73 is 40.4% above this benchmark. Historically, Precise Biometrics AB's own Equity-to-Asset has ranged from 0.53 to 0.86 over the past decade. While the company's 10-year median is 0.75 vs. the industry median of 0.52, Precise Biometrics AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Business Services company?
The median Equity-to-Asset among Business Services companies is 0.52, based on 1,096 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Precise Biometrics AB's current Equity-to-Asset of 0.73 is 40.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Precise Biometrics AB and its competitors. For the Business Services industry, the median Equity-to-Asset is 0.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Precise Biometrics AB's current Equity-to-Asset is 0.73, which is near median its own 10-year median of 0.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Precise Biometrics AB stock overvalued right now?
Based on GuruFocus' analysis, Precise Biometrics AB (PRBCF) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.23, compared to a current price of $0.18 — trading 21.7% below its estimated fair value. The current Equity-to-Asset is 0.73, which is near median its 10-year median of 0.75 and 40.4% above the Business Services industry median of 0.52. Precise Biometrics AB's overall GF Score™ is 34/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Precise Biometrics AB (PRBCF), the current Equity-to-Asset is 0.73 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Precise Biometrics AB (PRBCF) Overvalued in 2026?
Based on GuruFocus' analysis, Precise Biometrics AB stock appears to be undervalued.
The current stock price of $0.18 is trading 21.7% below its estimated GF Value™ of $0.23.
GuruFocus considers Precise Biometrics AB to be Modestly Undervalued.
Key valuation signals for PRBCF:
Equity-to-Asset: 0.73 (near median its 10-year median of 0.75)
GF Value™: $0.23 vs. price of $0.18 (21.7% below fair value)
Industry Position: 40.4% above the Business Services median (#240 of 1096)
No single metric tells the full story. See the PRBCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Precise Biometrics AB is engaged in the business of developing and selling identification software for the authentication of people's identity in mobile phones, laptops, smart cards, and products with sensors. The company has two product segments: Digital Identity and Biometric Technologies. In the Biometric Technologies segment which generates key revenue, the company licenses, among other things, its fingerprint software to sensor manufacturers and includes products like BioMatch, BioLive, and BioEnhance. The Digital Identity segment offers system solutions for visitor management and physical biometric access. The company provides premium solutions that enable secure and seamless access to data, mobile devices, premises, and trusted identities.
34GF Score
Get the complete analysis for PRBCF
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PRBCF has been successfully added to your 
